⌘K

Home/Filings/4/0001493152-18-014009

4//SEC Filing

GLECKEL LOUIS MD 4

Accession 0001493152-18-014009

CIK 0000868278other

View on SEC.gov Company Profile

Filed

Oct 1, 8:00 PM ET

Accepted

Oct 2, 5:20 PM ET

Size

4.8 KB

Accession

0001493152-18-014009

Insider Transaction Report

Form 4

Period: 2018-10-01

ProPhase Labs, Inc.PRPH

GLECKEL LOUIS MD

10% Owner

Transactions

Award
Common Stock, par value $0.0005
2018-10-01$3.01/sh+3,737$11,248→ 86,709 total

Footnotes (1)

[F1]These shares of common stock were issued pursuant to the terms of the 2010 Directors' Equity Compensation Plan, as amended, for quarterly director fees payable to non-employee directors.

Documents

1 file

4
ownership.xmlPrimary

Issuer

ProPhase Labs, Inc.

CIK 0000868278

Entity typeother

Related Parties

1

filerCIK 0001164762

Filing Metadata

Form type: 4
Filed: Oct 1, 8:00 PM ET
Accepted: Oct 2, 5:20 PM ET
Size: 4.8 KB

View on SEC.gov